Medicare Enrolled
Dr. Michael Dimarino, M.D.
Gastroenterology · Phila, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dimarino from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dimarino?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dimarino
Dr. Michael Dimarino is a gastroenterology specialist in Phila, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dimarino performed 905 Medicare services across 798 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dimarino received a total of $11,039 from 48 pharmaceutical and/or device companies across 409 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dimarino is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 18% volume in PA
$11,039 industry payments
Medicare Practice Summary
Medicare Utilization ↗905
Medicare services
Top 18% in PA for gastroenterology
798
Unique beneficiaries
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~45 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
211 | $92 | $228 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
165 | $97 | $1,211 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
111 | $66 | $150 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
92 | $211 | $1,329 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
90 | $107 | $285 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
86 | $61 | $893 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
64 | $120 | $280 |
| Esophageal dilation with guide wire and endoscope A flexible endoscope is used to insert a guide wire into the esophagus, followed by dilation to widen the esophageal passage. |
22 | $95 | $968 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
21 | $65 | $185 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
16 | $112 | $305 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
15 | $68 | $205 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
12 | $144 | $406 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.8% high complexity
27.7% medium
70.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,039
Total received (2018-2024)
Avg $1,577/year across 7 years
Top 16% in PA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
409
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,469 (58.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,556 (41.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$14 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$855
2023
$909
2022
$1,250
2021
$636
2020
$406
2019
$740
2018
$6,243
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$222
Lilly USA, LLC
$96
Janssen Biotech, Inc.
$65
IRONWOOD PHARMACEUTICALS, INC
$63
Ipsen Biopharmaceuticals, Inc
$61
Takeda Pharmaceuticals U.S.A., Inc.
$52
Celgene Corporation
$47
Regeneron Healthcare Solutions, Inc.
$36
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$32
QOL Medical, LLC
$22
GENZYME CORPORATION
$21
Sandoz Inc.
$20
Ardelyx, Inc.
$19
Organon Llc
$19
Madrigal Pharmaceuticals
$18
EVOKE PHARMA, INC.
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Phathom Pharmaceuticals, Inc.
$16
Celltrion USA Inc.
$14
Top 3 companies account for 44.7% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$4,678
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$878
Romark Laboratories, LC
$607
ABBVIE INC.
$449
Takeda Pharmaceuticals U.S.A., Inc.
$427
AbbVie, Inc.
$425
AbbVie Inc.
$408
Janssen Biotech, Inc.
$354
Celgene Corporation
$282
Ferring Pharmaceuticals Inc.
$243
QOL Medical, LLC
$156
Medtronic, Inc.
$153
Gilead Sciences, Inc.
$148
Shire North American Group Inc
$128
UCB, Inc.
$120
Merck Sharp & Dohme Corporation
$114
Nestle HealthCare Nutrition Inc.
$113
Covidien LP
$107
Biogen, Inc.
$106
Regeneron Healthcare Solutions, Inc.
$102
Lilly USA, LLC
$96
Ironwood Pharmaceuticals, Inc
$95
Ardelyx, Inc.
$68
Laborie Medical Technologies Corp.
$65
Merck Sharp & Dohme LLC
$64
IRONWOOD PHARMACEUTICALS, INC
$63
Ipsen Biopharmaceuticals, Inc
$61
Allergan Inc.
$49
RedHill Biopharma Inc.
$44
Evoke Pharma, Inc.
$42
Daiichi Sankyo Inc.
$42
GENZYME CORPORATION
$39
Braintree Laboratories, Inc.
$36
Boehringer Ingelheim Pharmaceuticals, Inc.
$31
Synergy Pharmaceuticals Inc
$29
FUJIFILM Healthcare Americas Corporation
$28
Sandoz Inc.
$20
Organon Llc
$19
NESTLE HEALTHCARE NUTRITION INC.
$18
Madrigal Pharmaceuticals
$18
EVOKE PHARMA, INC.
$17
Phathom Pharmaceuticals, Inc.
$16
Intercept Pharmaceuticals, Inc.
$15
Alexion Pharmaceuticals, Inc.
$14
Janssen Pharmaceuticals, Inc
$14
Celltrion USA Inc.
$14
Endo Pharmaceuticals Inc.
$14
Concordia Pharmaceuticals Inc.
$13
Top 3 companies account for 55.8% of all-time payments
Associated products mentioned in payments ›
ALINIA · APRISO · Alinia · Alinia Tablets 500mg 30 count bottle · Amitiza · Bylvay · CIMZIA · CLENPIQ · CREON · CYLTEZO · Cimzia · Creon · DIFICID · DUPIXENT · Dexilant · Donnatal · ENTYVIO · EOHILIA · Entyvio · FUJIFILM · GATTEX · GI GENIUS · GI Genius · GIMOTI · HADLIMA · HUMIRA · HYRIMOZ · Humira · IBSRELA · INFLECTRA · INJECTAFER · IQIRVO · Kanuma · LINZESS · Linzess · MAVYRET · MOTEGRITY · Mavyret · Motegrity · NASCOBAL · NOXAFIL · OCALIVA · OMVOH · PREPOPIK · PillCam · REBYOTA · RELISTOR · RENFLEXIS · RESMETIROM · RINVOQ · SKYRIZI · SPINRAZA · STELARA · SUCRAID · SUPREP · SUPREP BOWEL PREP · SUTAB · Sucraid · TREMFYA · TRULANCE · Talicia · Trulance · UCERIS TABLETS · VEGZELMA · VIBERZI · VOQUEZNA · XARELTO · XELJANZ · XIFAXAN · XIFAXANIBSD · ZENPEP · ZEPATIER · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (59%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
424
Per 100K population
26.8
County median income
$60,698
Nearest hospital
THOMAS JEFFERSON UNIVERSITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dimarino is a clinical cardiology specialist, with above-average Medicare volume (top 18% in PA), with low-engagement industry engagement in the top 16% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dimarino experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Dimarino performed 211 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dimarino receive payments from pharmaceutical companies?
Yes. Dr. Dimarino received a total of $11,039 from 48 companies across 409 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dimarino's costs compare to other gastroenterologists in Phila?
Dr. Dimarino's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dimarino) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Phila
Browse gastroenterologists in Phila ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in PA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in PA
Which PA gastroenterologists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
Romark Laboratories, LC Payments to Doctors
See all physicians who received payments from Romark Laboratories, LC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology